Profile
Carolyn W.
Slayman has been a Director of Applera Corp.
since 1994 and Sterling Professor of Genetics and Deputy Dean for Academic and Scientific Affairs at Yale University School of Medicine since 1967 and a Consultant of the National Institutes of Health.
She was a Director of Applied Biosystems, Inc. until November 12, 2008.
Ms. Slayman was a Member of National Advisory General Medical Sciences Council.
Former positions of Carolyn W. Slayman
Companies | Position | End |
---|---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Director/Board Member | 2008-11-11 |
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Director/Board Member | 2008-06-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
- Stock Market
- Insiders
- Carolyn W. Slayman